Archive of Oncology 2009 Volume 17, Issue 1-2, Pages: 19-24
doi:10.2298/AOO0902019V
Full text ( 123 KB)


Molecular targets and gene therapy of lung cancer

Vasić Ljiljana

Lung cancer is of great interest in human pathology because its apparent aggressiveness cannot be stopped by applied treatment procedures. The lack of highly specific screening tests prevents an early diagnosis of the disease. Insidious beginning and diverse and unclear clinical picture are responsible for the fact that most cases are diagnosed at advanced stages. An increasing number of patients and a short length of survival are additional factors that make this disease an imperative in the clinical practice, while vague and mutually dependent etiological factors represent a challenge in laboratory studies of the pathogenesis. The objective of this review is to describe some of the potential molecular targets available for manipulation in lung cancer; vector currently used by thoracic investigators to deliver therapy, and illustrated the experience with clinical trials of gene therapy in lung cancer. While gene therapy offers new hopes for lung cancer treatment, it is the need to develop valid clinical protocols of randomized trials before safety using to various lung cancer patient populations.

Keywords: Lung Neoplasms, Gene Therapy, Clinical Trials as Topic, Clinical Protocols

More data about this article available through SCIndeks